Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis.

ABSTRACT:

SUBMITTER: Esteban D 

PROVIDER: S-EPMC4635190 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature